SCHEMBL630364

SCHEMBL630364

CC(C)(CN[CH]Cc1ccccc1)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP1A2 P05177 1/20 0.36
RECQL P46063 1/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 1/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HIF1A Q16665 1/20 0.35
LMNA P02545 1/20 0.35
PRSS1 P07477 1/20 0.35
CTSG P08311 1/20 0.35
CTRB1 P17538 1/20 0.35
CMA1 P23946 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL630686 0.75 POLB (0.42) RIPK1MAPTKMT2ACYP3A4ALDH1A1
SCHEMBL8759 0.74 SLC6A2 (0.56) RIPK1MAPTKMT2ACYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL3136989 0.72 SLC6A2 (0.54) RIPK1MAPTKMT2ACYP3A4ALDH1A1
SCHEMBL5892305 0.72 MAOB (0.44) KMT2ACYP2C9CYP2C19CYP1A2MAPK1
SCHEMBL28904890 0.71 MAPT (0.46) MAPTKMT2ARAB9AHIF1APRSS1
SCHEMBL6803588 0.71 HDAC3 (0.50) RIPK1MAPTKMT2AALDH1A1RAB9A
SCHEMBL4040412 0.70 KDM4E (0.54) MAPTKMT2AALDH1A1RAB9APOLB
SCHEMBL292365 0.70 SMN1; SMN2 (0.54) MAPTALDH1A1RAB9ANPC1SMN1; SMN2
SCHEMBL27748312 0.69 CYP3A4 (0.42) RIPK1MAPTKMT2ACYP3A4ALDH1A1
SCHEMBL28208793 0.68 LMNA (0.51) MAPTKMT2AALDH1A1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-B1 FKBP-binding composition and pharmaceutical use thereof AVENTIS PHARMA INC (US) 2012-02-22 EP claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed